CSNK2A1 and breast carcinoma: Previous studies (85–89) have demonstrated that CSNK2A1 promotes tumorigenesis by enhancing several oncogenic signaling pathways in various malignancies, including breast cancer, lung cancer, kidney cancer, colorectal cancer, and prostate cancer.